Future Projections: Leukemia Therapeutics Treatment Market By 2023 to 2033

 The global leukemia therapeutics treatment market value is USD 15,246.7 million in 2023. In contrast, the 2022 value was USD 14,504.8 million. The market is set to progress at a CAGR of 7.1% through 2033. By the end of the forecast period, the valuation of the market is expected to reach USD 30,318.5 million.  

An increase in leukemia cases necessitates leukemia therapeutics treatment. The players in the market are taking increasingly innovative steps to combat leukemia in patients. The introduction of new drugs and treatments, after approval, is aimed at improving the efficiency of treatment. Technology thus plays a key role in the market.

Get your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-421

Survival rates of leukemia patients are rising due in large part to leukemia treatments. Thus, the leukemia therapeutics treatment market has a positive image in the market. Combined with positive attitudes towards cancer care and preventive healthcare, the market is thus flourishing.

Patients of leukemia encompass all age groups. However, a few age groups are more susceptible to the disease. Patients 65 and above years of age and 20 and below years of age represent a significant consumer base for the market.    

 “To come up with breakthroughs in treatment as well as innovations in drugs, significant investment is needed. Companies invest in research and development to make treatment more efficient. Governments all over the world are backing the research for developing efficient leukemia treatment methods. Thus, there are lucrative opportunities for players in the leukemia therapeutics treatment market,” says an analyst at FMI.

Key Takeaways from the Leukemia Therapeutics Treatment Market:

  • The leukemia therapeutics treatment market is likely to be valued at USD 30,318.5 million by 2033.
  • Patients prefer injectable medicines, which accounted for 61.7% of the market share by mode of administration in 2022.
  • Patients are most commonly using targeted drugs and immunotherapy as treatment. Targeted drugs & immunotherapy made up 57.2% of the market share by treatment in 2022.
  • China is expected to show rapid growth in the market. The CAGR of the market in China is forecasted at 10.6% through 2033.
  • Another Asian market with great potential is South Korea. The South Korean market is expected to grow at a CAGR of 9.6% over the forecast period.
  • The market is projected to grow at a CAGR of 9.6% and 8.6% in Japan and India, respectively.

Competition Analysis of the Leukemia Therapeutics Treatment Market:

Through research and development, players in the market are focused on innovations. New drugs and breakthroughs not only improve the efficiency of treatment but also help bring diversity to portfolios of companies. Some of the prominent companies in the market include Ambit Biosciences Corporation, Biogen Idec, Inc., Ariad Pharmaceuticals, Inc., and Bristol-Myers Squibb.

Recent Developments in the Leukemia Therapeutics Treatment Market:

  • In October 2023, the drug Revumenib had success in the trial stage, as announced by the manufacturer Syndax Pharmaceuticals.
  • In November 2022, the European Council approved BeiGene’s drug Brukinsa (Zanubrutinib). Chronic lymphocytic leukemia (CLL) patients are the target group for the drug.
  • In September 2020, the Onureg drug from Bristol Myers Squibb was approved by the US Food and Drug Administration (FDA). The drug boasts of helping patients in remission.

Key Companies in the Leukemia Therapeutics Treatment Market:

  • Ambit Biosciences Corporation
  • Biogen Idec, Inc.
  • Ariad Pharmaceuticals, Inc.
  • Bristol-Myers Squibb
  • Novartis Pharmaceuticals
  • Pfizer
  • Others

Key Segments:

By Treatment:

  • Targeted Drugs & Immunotherapy
  • Chemotherapy

By Molecule:

  • Biologics
  • Single Molecule

By Mode of Administration:

  • Injectable
  • Oral

By Indication:

  • AML
  • CML
  • ALL
  • CLL

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more